What is Manual?
Manual operates as a comprehensive men's health platform, specializing in treatments for common conditions such as hair loss, low testosterone, and erectile dysfunction. The company distinguishes itself by offering science-backed prescription treatments, coupled with ongoing medical support and convenient at-home diagnostics. Manual's core mission is to revolutionize men's healthcare by enhancing accessibility and convenience, emphasizing a personalized approach to patient care. Their services are tailored for men seeking effective and discreet solutions to their health concerns, fostering a supportive and informative user experience.
How much funding has Manual raised?
Manual has raised a total of $33.5M across 2 funding rounds:
Angel/Seed
$3.5M
Series A
$30M
Angel/Seed (2019): $3.5M, investors not publicly disclosed
Series A (2021): $30M led by Cherry Ventures, Felix Capital Partners LLP, and Sonoma Brands
Key Investors in Manual
Cherry Ventures
Cherry Ventures is an early-stage investment firm focused on European startups, known for its hands-on approach and support for founders across various tech sectors. Their expertise in building successful companies likely aids Manual in scaling its operations and market strategy.
Felix Capital Partners LLP
Felix Capital Partners LLP is an investment firm that supports companies in the digital economy. Their involvement suggests a strategic alignment with Manual's digital-first approach to healthcare delivery.
Sonoma Brands
Sonoma Brands Capital is a private equity firm focused on growth-stage consumer businesses, aiming to build enduring brands. Their investment in Manual indicates a belief in the company's potential to scale and capture a significant share of the men's health market.
What's next for Manual?
The substantial enterprise-level funding positions Manual for accelerated growth and market penetration. With a recent strategic investment, the company is poised to expand its service offerings, enhance its technological infrastructure, and potentially broaden its geographic reach. This capital infusion will likely support further research and development into new treatment modalities and diagnostic tools, reinforcing Manual's commitment to innovation in men's health. The company's focus on personalized, accessible healthcare solutions suggests a strategic expansion into new service lines or partnerships to solidify its leadership in the digital health landscape.
See full Manual company page
